Using B16 melanoma or 3-methylcholanthrene (3-MCA)-induced skin cancer models, it has been shown that the incidence of tumor development in mice was impaired in IL-1β-deficient or in IL-RA-treated animals [67,68]. This evidence concerns the gene IL1B and skin cancer.